Pharmacology Xagena

Xagena Mappa
Xagena Newsletter
Medical Meeting

Search results for "Lenvatinib"

Lenvatinib ( Lenvima ) is an orally administered multiple receptor tyrosine kinase ( RTK ) inhibitor with a novel binding mode that selectively inhibits the kinase activities of vascular endothelial g ...

The European Medicines Agency ( EMA ) has recommended granting marketing authorisations in the European Union ( EU ) for two medicines for the treatment of advanced renal cell carcinoma, Cabometyx ...